Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
VIDEO: Hybrid Complete Health Improvement Program feasible for patients with type 2 diabetes
ORLANDO — A pilot study found a hybrid online/in-person version of the Complete Health Improvement Program could be feasible for patients with type 2 diabetes, according to a poster presented at the Lifestyle Medicine Conference.
‘This is the foundation’: New guideline emphasizes lifestyle-first approach to diabetes
ORLANDO — A first-ever clinical practice guideline from the American College of Lifestyle Medicine outlines practical recommendations for lifestyle interventions as first-line therapy for people with prediabetes or type 2 diabetes.
Log in or Sign up for Free to view tailored content for your specialty!
Many people with ultraprocessed food addiction not identified as needing treatment
BOSTON — Addiction to ultraprocessed food may be diagnosed similarly to other substance use disorders, and reducing stigma and tailored treatment are both important to improving cardiometabolic health, a speaker reported.
Semaglutide linked to reduced risk for Alzheimer’s in patients with diabetes
In patients with type 2 diabetes, semaglutide was associated with a significantly lower risk for an Alzheimer’s disease diagnosis within 3 years compared with other diabetes medications, according to a study published in Alzheimer’s & Dementia.
Top in endocrinology: GLP-1s may reduce suicide risk; type 2 diabetes after COVID-19
Adolescents prescribed a GLP-1 receptor agonist for obesity treatment reportedly had lower risk for suicidal thoughts and suicide attempts , according to researchers.
GLP-1, SGLT2 prescriptions for type 1 diabetes rising despite no regulatory approval
Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.
Low-carb diet may benefit beta-cell function in patients with type 2 diabetes
Patients with type 2 diabetes on a carbohydrate-restricted diet showed recovery in beta-cell function, researchers reported in The Journal of Clinical Endocrinology & Metabolism.
Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD
Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.
Speakers highlight 2024 regulatory moves in hypertension, lipid, diabetes therapies
There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.
Drugs for diabetes, weight loss may also help treat substance use disorders
Ozempic and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid and alcohol use disorders, a new study showed.
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read